Cytokinetics Inc vs Global X Defense Tech ETF — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Global X Defense Tech ETF trades at $69.7. The key difference: Cytokinetics Inc is trading nearer its 52-week high, Global X Defense Tech ETF nearer its low. Which is the better fit depends on your goals.
| CYTK | SHLD | |
|---|---|---|
Market Cap | $10.63B | — |
Sector | Technology | Sector/Thematic |
52-Week High | $87.26 | $78.02 |
52-Week Low | $34.31 | $58.20 |
Enterprise Value | $10.74B | — |
Trailing returns across standard periods
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →